Long-Term Adherence to Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis
Three-year adherence to ETI and IVA based on pharmacy refill data was high, yet declined over time.
Authors
- Patricia M. L. A. van den Bemt (ORCID: https://orcid.org/0000-0003-1418-5520)
- Annelies M. Zwitserloot (ORCID: https://orcid.org/0000-0003-4519-9511)
- Job F. M. van Boven (ORCID: https://orcid.org/0000-0003-2368-2262)
- Badr Zendaky
- Carina M. E. Hansen
Institutions
- University Medical Center Groningen (NL)
- Hanze University of Applied Sciences (NL)
Publication Details
- Journal
- Pulmonary Therapy
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1007/s41030-026-00351-4
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00